<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37334926</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Revealing common differential mRNAs, signaling pathways, and immune cells in blood, glomeruli, and tubulointerstitium of lupus nephritis patients based on transcriptomic data.</ArticleTitle><Pagination><StartPage>2215344</StartPage><MedlinePgn>2215344</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2215344</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2023.2215344</ELocationID><Abstract><AbstractText>Lupus nephritis (LN) is a potentially fatal autoimmune disease. The purpose of this study was to find potential key molecular markers of LN to aid in the early diagnosis and management of the disease. Datasets GSE99967_blood, GSE32591_glomeruli, and GSE32591_tubulointerstitium were included in this study. Differentially expressed mRNAs (DEmRNAs) were identified between the normal control and LN groups using the limma package in R. Common DEmRNAs in the three datasets were taken. Subsequently, functional enrichment analysis, immune correlation analysis, receiver operating characteristic (ROC) curve analysis and real-time polymerase chain reaction (RT-PCR) verification were performed. In this study, 11 common DEmRNAs were obtained and all of them were up-regulated. In protein-protein interaction (PPI) networks, we found that MX dynamin like GTPase 1 (MX1) and radical S-adenosyl methionine domain containing 2 (RSAD2) had the highest interaction score (0.997). Functional enrichment analysis revealed that MX1 and RSAD2 were enriched in influenza A and hepatitis C signaling pathways. The area under the curve (AUC) values of interferon-induced protein 44 (IFI44) and MX1 in GSE32591_glomeruli and GSE32591_tubulointerstitium datasets are 1, which is worthy of further study on their diagnostic value and molecular mechanism. The xCell analysis showed abnormal distribution of granulocyte-macrophage progenitor (GMP) cells in blood, glomeruli, and tubulointerstitium. Pearson's correlation analysis found that GMP cells were significantly correlated with lactotransferrin (LTF) and cell cycle. Identification of common DEmRNAs and key pathways in the blood, glomeruli, and tubulointerstitium of patients with LN provides potential research directions for exploring the molecular mechanisms of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Haifang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Dongying People's Hospital, Dongying, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Dongxia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Dongying People's Hospital, Dongying, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LTF</Keyword><Keyword MajorTopicYN="N">Lupus nephritis</Keyword><Keyword MajorTopicYN="N">MX1</Keyword><Keyword MajorTopicYN="N">cell cycle</Keyword><Keyword MajorTopicYN="N">differentially expressed mRNAs</Keyword><Keyword MajorTopicYN="N">immune cell infiltration</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>7</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37334926</ArticleId><ArticleId IdType="pmc">PMC10281411</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2023.2215344</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anders HJ, Saxena R, Zhao MH, et al. . Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):1.</Citation><ArticleIdList><ArticleId IdType="pubmed">31974366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocampo-Piraquive V, Nieto-Aristiz&#xe1;bal I, Ca&#xf1;as CA, et al. . Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert Rev Clin Immunol. 2018;14(12):1043&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">30338717</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaani S, Meara A, Rovin BH.. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5477208</ArticleId><ArticleId IdType="pubmed">27821390</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Cheema K, et al. . 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79(6):713&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pubmed">32220834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Alunno A, et al. . 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pubmed">30926722</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparotto M, Gatto M, Binda V, et al. . Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology. 2020;59(Suppl. 5):v39&#x2013;v51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751166</ArticleId><ArticleId IdType="pubmed">33280015</ArticleId></ArticleIdList></Reference><Reference><Citation>Arazi A, Rao DA, Berthier CC, et al. . The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019;20(7):902&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6726437</ArticleId><ArticleId IdType="pubmed">31209404</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap DYH, Chan TM.. B cell abnormalities in systemic lupus erythematosus and lupus nephritis&#x2014;role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci. 2019;20(24):6231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida N, He F, Kyttaris VC.. T cell-specific STAT3 deficiency abrogates lupus nephritis. Lupus. 2019;28(12):1468&#x2013;1472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6791775</ArticleId><ArticleId IdType="pubmed">31551033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lech M, Anders HJ.. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24(9):1357&#x2013;1366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3752952</ArticleId><ArticleId IdType="pubmed">23929771</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, Wang Z, Ye Q, et al. . High-throughput sequencing-based analysis of T cell repertoire in lupus nephritis. Front Immunol. 2020;11:1618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423971</ArticleId><ArticleId IdType="pubmed">32849548</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayed A, Mohamed A, Ahmed RA, et al. . Evaluation of urinary FOXP3 mRNA as a biomarker of lupus nephritis in Egyptian patients with systemic lupus erythematosus. Lupus. 2021;30(10):1631&#x2013;1636.</Citation><ArticleIdList><ArticleId IdType="pubmed">34238088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao YJ, Qin S, Jiao ZF.. Wnt pathway regulates IL-34 level in lupus nephritis. Eur Rev Med Pharmacol Sci. 2019;23(12):5360&#x2013;5365.</Citation><ArticleIdList><ArticleId IdType="pubmed">31298388</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XD, Huang XF, Yan QR, et al. . Aberrant activation of the WNT/&#x3b2;-catenin signaling pathway in lupus nephritis. PLOS One. 2014;9(1):e84852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3897389</ArticleId><ArticleId IdType="pubmed">24465439</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Huang X, Liu J, et al. . New insight into long non-coding RNAs associated with bone metastasis of breast cancer based on an integrated analysis. Cancer Cell Int. 2021;21(1):372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276423</ArticleId><ArticleId IdType="pubmed">34256750</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Jia B, Zhao X, et al. . Pathophysiology and system biology of rat c-BSA induced immune complex glomerulonephritis and pathway comparison with human gene sequencing data. Int Immunopharmacol. 2022;109:108891.</Citation><ArticleIdList><ArticleId IdType="pubmed">35691274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Goto S.. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102409</ArticleId><ArticleId IdType="pubmed">10592173</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittrich T, Marsch S, Egli A, et al. . Predictors of infectious meningitis or encephalitis: the yield of cerebrospinal fluid in a cross-sectional study. BMC Infect Dis. 2020;20(1):304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181581</ArticleId><ArticleId IdType="pubmed">32326881</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;imundi&#x107; AM. Measures of diagnostic accuracy: basic definitions. EJIFCC. 2009;19(4):203&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4975285</ArticleId><ArticleId IdType="pubmed">27683318</ArticleId></ArticleIdList></Reference><Reference><Citation>Aran D, Hu Z, Butte AJ.. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5688663</ArticleId><ArticleId IdType="pubmed">29141660</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD.. Analysis of relative gene expression data using real-time quantitative PCR and the 2(&#x2013;delta delta C(T)) method. Methods. 2001;25(4):402&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu Y, Yasuda S, Kimura T, et al. . Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-na&#xef;ve lupus nephritis, but not in those under immunosuppressive treatment. Mod Rheumatol. 2018;28(4):661&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">29189089</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Imaizumi T, Tsuruga K, et al. . Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis. Nephrology. 2013;18(12):833&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">24674141</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J, Song W, Tian L, et al. . Potential small molecules for therapy of lupus nephritis based on genetic effect and immune infiltration. Biomed Res Int. 2022;2022:2259164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9056222</ArticleId><ArticleId IdType="pubmed">35502341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Zhang L, Wang J, et al. . Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. J Transl Med. 2021;19(1):35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7814551</ArticleId><ArticleId IdType="pubmed">33468161</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi KZ, Wilhelm TR, Ulff-M&#xf8;ller CJ, et al. . Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies. Transl Res. 2021;238:63&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">34343626</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, Jeffries M, Altorok N, et al. . Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in na&#xef;ve CD4+ T cells from lupus patients. J Autoimmun. 2013;43:78&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3790645</ArticleId><ArticleId IdType="pubmed">23623029</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitwalli AH, Hayat A, Alwakeel J, et al. . Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome. Nephrol Dial Transplant. 2012;27(2):627&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">21771749</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura H, Fujieda Y, Yasuda S, et al. . Remission of nephrotic syndrome after therapy for chronic hepatitis C virus infection in a patient with systemic lupus erythematosus. Ann Intern Med. 2018;169(5):352&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">29710334</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim JJL, Lim CC.. Influenza vaccination in systemic lupus erythematosus: efficacy, effectiveness, safety, utilization, and barriers. Am J Med. 2022;135(3):286&#x2013;296.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34563493</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe SR, Merrill JT, Vista ES, et al. . Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum. 2011;63(8):2396&#x2013;2406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3149742</ArticleId><ArticleId IdType="pubmed">21598235</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia-Vilet JM, Zhang XL, Cruz C, et al. . Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis. J Am Soc Nephrol. 2020;31(6):1335&#x2013;1347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269356</ArticleId><ArticleId IdType="pubmed">32300067</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Yadav A, Aggarwal A.. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis. Clin Rheumatol. 2021;40(3):941&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">32809146</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L, Lan L, Zhu T, et al. . Identification and validation of IFI44 as key biomarker in lupus nephritis. Front Med. 2021;8:762848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574154</ArticleId><ArticleId IdType="pubmed">34760904</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, Renauer P, Jeffries MA, et al. . Renal involvement in lupus is characterized by unique DNA methylation changes in na&#xef;ve CD4+ T cells. J Autoimmun. 2015;61:29&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4497927</ArticleId><ArticleId IdType="pubmed">26005050</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes Andrade F, Goeldner Eibofner I, Pieczarka C, et al. . Impact of VSIG4 gene polymorphisms on susceptibility and functional status of rheumatoid arthritis. Int J Immunogenet. 2021;48(3):260&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">33645007</ArticleId></ArticleIdList></Reference><Reference><Citation>He JQ, Wiesmann C, van Lookeren Campagne M.. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol. 2008;45(16):4041&#x2013;4047.</Citation><ArticleIdList><ArticleId IdType="pubmed">18752851</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Yao W, Sun L, et al. . The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice. BMC Nephrol. 2019;20(1):424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6873683</ArticleId><ArticleId IdType="pubmed">31752725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman LA, Mizui M, Nalbandian A, et al. . Complement receptor of the immunoglobulin superfamily reduces murine lupus nephritis and cutaneous disease. Clin Immunol. 2015;160(2):286&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">25988858</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Tang W, Tang W.. Immune cell infiltration characteristics and related core genes in lupus nephritis: results from bioinformatic analysis. BMC Immunol. 2019;20(1):37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6805654</ArticleId><ArticleId IdType="pubmed">31638917</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LJ, Yan C, Schouteden S, et al. . The impact of integrin &#x3b2;2 on granulocyte/macrophage progenitor proliferation. Stem Cells. 2019;37(3):430&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6849781</ArticleId><ArticleId IdType="pubmed">30537419</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Zhang P, Yu X, et al. . Lead transiently promotes granulocyte-macrophage progenitor differentiation and subsequently suppresses common myeloid progenitor differentiation. Toxicol Sci. 2017;160(2):268&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">28973681</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Lin Z, Feng J, et al. . Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis. Lupus. 2022;31(8):985&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pubmed">35588147</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, Dong G, Zhao G, et al. . Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen. J Immunol Res. 2014;2014:814598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3987971</ArticleId><ArticleId IdType="pubmed">24741625</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>